First-Line Jaktinib for Acute Graft-Versus-Host Disease (aGVHD)
First-Line Jaktinib for Acute Graft-Versus-Host Disease (aGVHD)
Recruiting · NCT07285889 · Registry updated 2025-12-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First-Line Jaktinib for Acute Graft-Versus-Host Disease (aGVHD) | acute graft versus host disease | Recruiting | Phase 1 / Phase 2 | 2025-12-16 | NCT07285889 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| First Affiliated Hospital of Zhejiang University | 201 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital, Zhejiang University School of Medicine. | Hangzhou | China | 3 |